On the contrary, CCL3 failed to block the cell cycling of primitive CML progenitors, when it was added to similar long-term cultures containing normal bone marrow adherent cell layers but supporting CML hematopoiesis. Here, CCL3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.